Author

Daniel Grasso

Universidad de Buenos AiresORCID 0000-0002-8932-716XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Analía Meilerman Abuelafia· 1 shared Eduardo ChuluyániD· 1 shared Gwen Alyce LomberkiD· 1 shared Juan IovannaiD· 1 shared Matías EstarásiD· 1 shared Nelson DusettiiD· 1 shared Nicolas Alejandro FraunhofferiD· 1 shared Patricia Santofimia‐CastañoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Analía Meilerman Abuelafia

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

KRAS Inhibition Reverses Chemotherapy Resistance Promoted by Therapy-Induced Senescence-like in Pancreatic Ductal Adenocarcinoma

Analía Meilerman Abuelafia, Patricia Santofimia‐Castaño, Matías Estarás, Daniel Grasso, Eduardo Chuluyán, Gwen Alyce Lomberk, Raul A. Urrutia, Nelson Dusetti, Nicolas Alejandro Fraunhoffer, Juan Iovanna

This study shows that KRAS inhibition can reverse chemotherapy resistance in PDAC by targeting therapy-induced senescence-like cells, with ERK pathway involvement.

Translational Oncology · May 17, 2025Peer-reviewedCancer Biology